ALLERGY THERAPEUTICS PLC — AGM Information 2014

Nov 19, 2014

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 4607X

Allergy Therapeutics PLC

19 November 2014

19 November 2014

Allergy Therapeutics plc

("Allergy Therapeutics" or the 'Company")

Result of Annual General Meeting

Allergy Therapeutics plc announces that at the Annual General Meeting held today, all the resolutions put to that meeting were duly passed.

For further information

Allergy Therapeutics	+44 (0) 1903 845 820
Manuel Llobet, Chief Executive Officer
Ian Postlethwaite, Finance Director
Peel Hunt LLP	+44 (0) 20 7418 8900
James Steel
Clare Terlouw
FTI Consulting	+44 (0) 20 3727 1000
Simon Conway
Victoria Foster Mitchell

Note to editors

About Allergy Therapeutics

Allergy Therapeutics is a specialty pharmaceutical company focused on allergy vaccination.Ithas a growing business achieving revenue in thelast financial year of £42 million mainly in Europe through its own sales and

marketing infrastructure and further afield through distributors.The Company is expanding its infrastructure into  the Emerging markets.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RAGFFSFDUFLSEFF